Wechselwirkungen · Savene
Savene 20 mg/ml powder and solvent for concentrate for solution for infusion. · Abschnitt 4.5 · PDF-Seite 4
HOS-208617 · Präparat HOS-154145
Concomitant use not recommended: • Other live attenuated vaccines: risk of systemic, possible fatal disease. This risk is increased in subjects who are already immunosuppressed by their underlying disease or by concomitant chemotherapy. Use an inactivated vaccine where this exists (poliomyelitis). • Dimethylsulfoxide (DMSO) should not be used in patients who are administered dexrazoxane to treat anthracycline extravasation (see section 5.3) • Phenytoin: cytotoxic agents may reduce the absorption of phenytoin leading to an exacerbation of convulsions. Dexrazoxane is not recommended in combination with phenytoin.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
RxNorm-Namen im Text (wörtliche Treffer, Rolle nicht bewertet): phenytoin (HOS-084531)
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2024-09-06T02:00:00Z · SHA-256 03ad60d30f6868bb116937dbef5ce0b32c0dc2bb4b4d32174d098c462660e73f · Passage 4ae68d57502b111f61394eb69ebda375d52b15b1dae166cbacd7a5c77aa80d17 · Zeichen 119–766 im Abschnitt